Sun Pharma Advanced Research Company Limited (NSE:SPARC)

NSE:SPARC Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 19, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	52,154	119,521	58,203	80,734	37,250	25,274
Market Cap Growth	-30.07%	105.35%	-27.91%	116.74%	47.38%	-49.53%
Enterprise Value	53,105	116,002	60,088	81,455	38,052	24,802
Last Close Price	160.71	368.30	179.35	296.95	142.15	96.45
Forward PE	-	91.22	91.22	91.22	91.22	91.22
PS Ratio	85.31	158.21	24.38	58.82	14.73	32.90
PB Ratio	-67.40	95.04	11.35	258.55	-22.14	-135.60
P/TBV Ratio	-	143.93	11.94	995.49	-	-
EV/Sales Ratio	86.87	153.55	25.17	59.35	15.04	32.29
Debt / Equity Ratio	-1.31	0.49	0.03	2.54	-1.40	-3.67
Asset Turnover	-	0.11	0.43	0.54	1.01	0.23
Inventory Turnover	-	28.64	26.43	25.15	20.05	14.00
Quick Ratio	-	0.81	2.47	0.25	0.14	0.11
Current Ratio	-	1.02	2.54	0.42	0.27	0.28
Return on Equity (ROE)	-	-121.28%	-81.83%	-	-	-225.08%
Return on Assets (ROA)	-	-38.26%	-25.18%	-48.08%	-36.26%	-58.67%
Return on Capital (ROIC)	-130.30%	-71.94%	-43.76%	-137.25%	-154.56%	-113.27%
Earnings Yield	-7.45%	-3.24%	-3.82%	-2.52%	-4.06%	-12.36%
FCF Yield	-	-3.81%	-1.45%	-2.98%	-4.24%	-10.48%
Buyback Yield / Dilution	-0.23%	-13.99%	-8.19%	-0.42%	-	-2.52%

Updated Feb 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.